Nuevolution to Receive License Fee Payment of USD 750,000
- Thursday, January 4, 2018, 1:50
- PR Newswire
- Add a comment
STOCKHOLM, Jan. 4, 2018 /PRNewswire/ — Nuevolution AB (publ) (NUE.ST) today announced that Janssen Biotech, one of the Pharmaceutical Companies of Johnson & Johnson, has exercised its option to license one of the research programs under the multi-target collaboration entered between…
Source: https://www.prnewswire.com/news-releases/nuevolution-to-receive-license-fee-payment-of-usd-750000-300577473.html
About the Author
admin has written 20652 stories on this site.